Chicago Partners Investment Group’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
– Sell
-118
Closed -$15K – 1065
2018
Q2
$15K Hold
118
– – ﹤0.01% 714
2018
Q1
$13K Buy
+118
New +$13.1K ﹤0.01% 724
2017
Q4
– Sell
-195
Closed -$19K – 887
2017
Q3
$19K Sell
195
-5
-3% -$485 ﹤0.01% 635
2017
Q2
$24K Buy
+200
New +$21.6K 0.01% 488

Other funds holding CLB

Chicago Partners Investment Group's CLB Position: Q3 2018 in Review

Chicago Partners Investment Group sold out of Core Laboratories (CLB) in Q3 2018, closing a stake of 118 shares — an estimated $15K sold.

Chicago Partners Investment Group first reported a position in CLB in Q2 2017 and held it in 4 quarters. The position peaked at $24K in Q2 2017. 359 funds tracked by Wall St. Rank hold CLB as of Q3 2018.

  • Chicago Partners Investment Group reported no remaining Core Laboratories position as of Q3 2018 after selling out during the quarter.
  • Chicago Partners Investment Group sold 118 Core Laboratories shares in Q3 2018, an estimated $15K.
  • Chicago Partners Investment Group first reported a position in Core Laboratories in Q2 2017 and held it in 4 quarters.
  • Chicago Partners Investment Group's Core Laboratories position peaked at $24K in Q2 2017.
  • 359 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2018.

Based on Chicago Partners Investment Group's 13F filing for Q3 2018, filed 5 Nov 2018.